Researchers found cognitive function and working memory in older people declined more rapidly during the pandemic
Lockdowns and other restrictions brought in during the pandemic have had a “real lasting impact” on the brain health of people over the age of 50, researchers have suggested.
Analysis showed the rate of cognitive decline quickened in the first year of the pandemic, and was higher among those who had already shown signs of mild cognitive decline before the outbreak of Covid-19. She added that it is “now more important than ever” to make sure people showing signs of early cognitive decline are supported.
“In doing so, it underlines the fact that there are steps we can all take to protect the health of our brain, she added.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Pandemic had real lasting impact on cognitive function in over-50s, study findsResearchers found cognitive function and working memory in older people declined more rapidly during the pandemic
Lire la suite »
Wigston: Arrest after cyclist seriously injured in collisionA man in his 50s was taken to hospital and continues to receive treatment, say police.
Lire la suite »
Researchers use AI to identify potential gonorrhea vaccine proteinsGonorrhea, a sexually transmitted bacterial infection that affects more than 80 million people worldwide every year, has become resistant to almost all known antibiotics. That makes it notoriously difficult to treat, but left untreated, an infection could lead to serious or even fatal complications.
Lire la suite »
Researchers Discover Potential Therapy for Triple-Negative Breast CancerResearchers at Baylor College of Medicine have identified a potential therapy for triple-negative breast cancer (TNBC) by targeting the protein eIF4A with a small molecule drug called Zotatifin. The drug not only suppresses tumor cell proliferation but also remodels the tumor immune microenvironment, leading to improved outcomes. Clinical trials are now being considered to assess the potential benefits of this approach.
Lire la suite »
Researchers identify key protein biomarkers in MS patients, paving way for personalized treatment strategiesResearchers aimed to identify dependable protein biomarkers for multiple sclerosis (MS).
Lire la suite »